Tumor Angiogenesis, New England Journal of Medicine, vol.358, issue.19, pp.2039-2049, 2008. ,
DOI : 10.1056/NEJMra0706596
Angiogenesis in cancer, vascular, rheumatoid and other disease, Nature Medicine, vol.326, issue.1, pp.27-31, 1995. ,
DOI : 10.1038/359845a0
Angiogenesis in cancer and other diseases, pp.249-257, 2000. ,
Antiangiogenic and antivascular therapy for cancer, Current Opinion in Pharmacology, vol.1, issue.4, pp.378-384, 2001. ,
DOI : 10.1016/S1471-4892(01)00065-0
Disrupting tumour blood vessels, Nature Reviews Cancer, vol.48, issue.8, pp.423-435, 2005. ,
DOI : 10.1038/sj.bjc.6690416
Bevacizumab plus Irinotecan, Fluorouracil, and Leucovorin for Metastatic Colorectal Cancer, New England Journal of Medicine, vol.350, issue.23, pp.2335-2342, 2004. ,
DOI : 10.1056/NEJMoa032691
Addition of Bevacizumab to Bolus Fluorouracil and Leucovorin in First-Line Metastatic Colorectal Cancer: Results of a Randomized Phase II Trial, Journal of Clinical Oncology, vol.23, issue.16, pp.3697-3705, 2005. ,
DOI : 10.1200/JCO.2005.05.112
Randomized Phase III Trial of Capecitabine Compared With Bevacizumab Plus Capecitabine in Patients With Previously Treated Metastatic Breast Cancer, Journal of Clinical Oncology, vol.23, issue.4, pp.792-799, 2005. ,
DOI : 10.1200/JCO.2005.05.098
Vascular-targeting therapies for treatment of malignant disease, Cancer, vol.88, issue.12, pp.2491-2499, 2004. ,
DOI : 10.1002/cncr.20299
Vascular targeting agents. Horizons in cancer therapeutics: From bench to ,
DOI : 10.1016/s0360-3016(02)04141-x
URL : http://ufdc.ufl.edu/LS00000881/00112